Insiders Cartesian Therapeutics, Inc.

Equities

RNAC

US8162123025

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-10 pm EDT			5-day change	1st Jan Change
32.39 ^USD	-11.45%		-10.03%	+56.61%

Jun. 04	Oppenheimer Initiates Cartesian Therapeutics With Outperform Rating, $50 Price Target	MT
May. 24	Mizuho Securities Starts Cartesian Therapeutics With Buy Rating	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cartesian Therapeutics, Inc. Announces Resignation of Aymeric Sallin as Member of the Board of Director and Member of Compensation Committee	Mar. 05	CI
Cartesian Therapeutics, Inc. Announces Resignation of Scott D. Myers as Member of the Board, Compensation and Nominating and Corporate Governance Committees	Nov. 27	CI
Peter Traber, Selecta Biosciences, Inc.?s Chief Medical Officer, Moves to Part-Time Status as Chief Medical Officer, Effective as of November 6, 2023	23-10-31	CI
Selecta Biosciences, Inc. Announces Retirement of Göran A. Ando, M.D. from Member of the Board of Directors	23-01-09	CI
Selecta Biosciences Names Blaine Davis CFO	22-11-28	MT
Selecta Biosciences, Inc. Announces Appointment of Blaine Davis as Chief Financial Officer	22-11-28	CI
Insider Buy: Selecta Biosciences	22-06-15	MT
Insider Buy: Selecta Biosciences	21-12-13	MT
Selecta Biosciences : Names Kevin Tan Finance Chief	21-09-20	MT
Selecta Biosciences : Hires Kevin Tan as CFO	21-09-20	MT
Selecta Biosciences, Inc. Announces Management Changes	21-09-20	CI
Selecta Biosciences, Inc. Announces Appointment of Jude Samulski, Ph.D. as Gene Therapy Special Advisor	21-07-26	CI
Selecta Biosciences, Inc. Appoints Nishan de Silva to Board of Directors	21-06-24	CI
Insider Trends: Insider Purchase Continues Selecta Biosciences Positive Trend	21-05-26	MT
Insider Trends: Selecta Biosciences Insider 90-Day Buying Trend Prolonged with Purchase	21-05-25	MT
Selecta Biosciences, Inc. Appoints Ann K. Donohue as the Company's Principal Accounting Officer and Principal Financial Officer on an Interim Basis	21-05-13	CI
Insider Trends: Insider Purchase of Selecta Biosciences Stock Prolongs 90-Day Positive Trend	20-12-16	MT
Selecta Biosciences, Inc. Appoints Peter G. Traber as Chief Medical Officer	20-08-03	CI
Selecta Biosciences, Inc. Announces Management Changes, Effective August 18, 2020	20-06-25	CI
Selecta Biosciences, Inc. Announces Board Changes	20-04-27	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Cartesian Therapeutics, Inc.

Equities

RNAC

US8162123025

Insiders

Filters